Lexeo Therapeutics - LXEO Net Assets per Single Share

Graphic logo of Lexeo Therapeutics, Inc. (LXEO)

Market valuation dynamics on GURU.Markets reflect Lexeo Therapeutics (LXEO), which specializes in precision treatment of heart and CNS pathologies, including Alzheimer's disease therapy, where the indicator stands at 3.01. A team of top-tier geneticists is retained through a stock option system, ensuring a stable workforce for conducting trials. The company's revenues are based on licensing fees and future sales of innovative drugs.

Lexeo Therapeutics (LXEO) Equity per Share: for the period 02/21/2024 - 10/27/2026
Manufactured products of Lexeo

Book value per share reflects the portion of the company's net assets attributable to a single security after deducting all liabilities from total equity. By analyzing the equity per share, an investor can see the tangible asset base of Lexeo Therapeutics (LXEO), which is supported by cost optimization through the outsourcing of drug production, confirming the asset's fundamental stability.

Competitor analysis

TEM (Tempus AI, Inc.) - Book Value per Share|QGEN: Net Asset Value per Share|Net Assets per Single Share IONS|repligen.com (RGEN) - Net Asset Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|TWST - Net Assets per Single Share|TXG - Net Assets per Single Share|Book Value per Share NTLA|Net Asset Value per Share Stoke Corp|Accounting Value per Share BioLife Solutions, Inc. (BLFS)|Equity per Share wavelifesciences.com|Maze Therapeutics - Book Value per Share|Net Asset Value per Share SION (Sionna Therapeutics, Inc.)|PRME: Net Assets per Single Share|TSHA - Net Asset Value per Share|Accounting Value per Share uniQure N.V. (QURE)|meiragtx.com (MGTX) - Accounting Value of a Share|RGNX - Accounting Value per Share|Solid Biosciences Inc (SLDB) - Book Price of a Share|OCGN - Book Value per Share|Accounting Value of a Share PacBio Corp|Benitec Biopharma Inc. - Book Value per Share|Net Asset Value per Share DSGN (designtx.com)|Net Assets per Single Share Rocket Pharmaceuticals, Inc.|Accounting Value of a Share 4DMT FDMT|Korro Bio, Inc - Book Value per Share|EDIT: Book Value per Share|Net Assets per Single Share Silence Therapeutics (SLN)|ProQR Therapeutics (PRQR) - Share Book Value|Book Value per Share CDXS (Codexis Inc)|Net Asset Value per Share Sangamo Therapeutics Inc. (SGMO)|Accounting Value per Share NAUT|Book Value per Share Metagenomi Therapeutics MGX|Accounting Value per Share Precision BioSciences, Inc. (DTIL)|Book Price of a Share Generation Bio Co GBIO|Book Value per Share BOLD (Boundless Bio)|XCUR - Net Assets per Share|IMNN (imunon.com) - Book Value per Share|PHIO (Phio Pharmaceuticals Corp.) - Accounting Value per Share|MBIO: Net Assets per Single Share|Net Assets per Share RNAZ|Net Assets per Single Share Bionano Genomics, Inc. (BNGO)|Net Assets per Single Share Applied DNA Sciences Inc APDN|BLUE - Accounting Value per Share|Equity per Share ImmunoPrecise Antibodies Ltd IPA|OMGA (Omega Therapeutics) - Book Value per Share|OMIC: Net Asset Value per Share|Net Assets per Single Share RGLS|Syros Pharmaceuticals Inc. (SYRS) - Net Asset Value per Share|Book Value per Share Codex DNA (TBIO)|Equity per Share TCON|Net Assets per Single Share Unity Biotechnology UBX